# Impress

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/impress

- Industry: Healthcare
- Headquarters: Barcelona, Spain
- Website: www.smile2impress.com
- Total disclosed funding: $201M
- Latest round: Debt (Oct 27, 2026)
- Investors on record: 12

## About

Based in Spain, Impress offers innovative orthodontic solutions such as clear aligners and professional teeth whitening, aiming to enhance dental aesthetics for adults and teens.Founded in 2019 in Barcelona, Spain, Impress focuses on clear orthodontic solutions. The founders include Diliara Lupenko, Irakli Katcharava, Khaled Kasem, Kjeld Aamodt, and Luis Gimenez, with Eleonora Ushatova as the CEO. The company has raised funding through 5 deals, with the most recent funding round, Series B, occurring on 2024-11-02, when Impress secured USD 100.00 mn from investors including Claret Capital Partners and Hayfin Capital Management. The total amount raised by the company stands at USD 100.00 mn.Impress specializes in modern orthodontic solutions with a focus on clear aligners for adults and teens, as well as offering professional teeth whitening and clear retainers. Their patented Root Diagnostic Technology supports orthodontic care for various dental issues like overbites and gaps, providing customized treatment plans for patients that usually span from several months to over a year. Impress operates in numerous markets, including major cities in the United States and across Europe, ensuring broad access to their services.In 2019, Impress generated revenue totaling USD 966,584.60, with an EBITDA of USD -125,093.90. The company's revenue model is based on direct-to-consumer transactions, with clients engaging in treatment plans involving clear aligners and other orthodontic services, typically financed through consultation processes and tailored payment options.In November 2024, Impress raised USD 40 mn in venture debt funding from Trinity Capital, as part of a larger USD 117 mn funding effort. This funding will support their expansion across Europe, including the opening of several new clinics. The company is focused on enhancing its product offerings and expanding its market presence to better serve its client base.

## Funding rounds

- Debt, Oct 27, 2026, $45M — Banco Europeo de Inversiones, European Investment Bank
- Series B, Jul 11, 2022, $100M — LBO France, UNIQA Group, TA Ventures, Hayfin Capital Management, Media Digital Ventures, Nickleby Capital, Claret Capital Partners
- Series A, May 10, 2021, $50M — UNIQA Group, TA Ventures, Bynd Venture Capital, CareCapital, Nickleby Capital
- Seed, Oct 8, 2020, $6.9M — TA Ventures, Bynd Venture Capital, Sabadell Venture Capital

## Investors

- TA Ventures (https://capitalatlas.ai/funds/ta-ventures) — Seed, Series A, Series B
- Bynd Venture Capital (https://capitalatlas.ai/funds/bynd-venture-capital) — Seed, Series A
- Sabadell Venture Capital (https://capitalatlas.ai/funds/sabadell-venture-capital) — Seed
- UNIQA Group — Series A, Series B
- CareCapital (https://capitalatlas.ai/funds/carecapital) — Series A
- Nickleby Capital (https://capitalatlas.ai/funds/nickleby-capital) — Series A, Series B
- LBO France (https://capitalatlas.ai/funds/lbo-france) — Series B
- Hayfin Capital Management (https://capitalatlas.ai/funds/hayfin-capital-management) — Series B
- Media Digital Ventures (https://capitalatlas.ai/funds/media-digital-ventures) — Series B
- Claret Capital Partners (https://capitalatlas.ai/funds/claret-capital-partners) — Series B
- Banco Europeo de Inversiones — Debt
- European Investment Bank (https://capitalatlas.ai/funds/european-investment-bank) — Debt